Table 1. Baseline characteristics.
Characteristic | Total (n=34) |
---|---|
Age, years | |
Median [range] | 60 [37–72] |
Sex, n (%) | |
Male | 23 (67.6) |
Female | 11 (32.4) |
ECOG PS, n (%) | |
0–1 | 25 (73.5) |
2 | 9 (26.5) |
Tumor histology, n (%) | |
Adenocarcinoma | 22 (64.7) |
Squamous | 8 (23.5) |
Other | 4 (11.8) |
Smoking status, n (%) | |
Current or former smoker | 17 (50.0) |
Never smoker | 17 (50.0) |
No. of prior systemic therapies, n (%) | |
1 | 8 (23.5) |
2 | 15 (44.1) |
>2 | 11 (32.4) |
No. of organs with metastasis, n (%) | |
≤2 | 24 (70.6) |
>2 | 10 (29.4) |
Brain metastasis, n (%) | |
Yes | 8 (23.5) |
No | 26 (76.5) |
Liver metastasis, n (%) | |
Yes | 9 (26.5) |
No | 25 (73.5) |
Prior anti-angiogenesis therapy, n (%) | |
Yes | 16 (47.1) |
No | 18 (52.9) |
ECOG PS, Eastern Cooperative Oncology Group performance status.